Today: 29 June 2026
Wesfarmers share price ticks higher after ASX close — what could move ASX:WES next week
16 January 2026
1 min read

Wesfarmers share price ticks higher after ASX close — what could move ASX:WES next week

Sydney, Jan 16, 2026, 17:31 AEDT — After-hours

  • Wesfarmers closed at A$83.21, rising A$0.22, or 0.27%.
  • Australia’s S&P/ASX 200 climbed 0.48% by Friday’s close.
  • Wesfarmers will release its half-year results on Feb. 19.

Wesfarmers Ltd (WES.AX) shares closed Friday 0.3% higher at A$83.21. The stock fluctuated between A$82.21 and A$83.24, with around 1.5 million shares changing hands.

The move was modest. Investors are already eyeing the weekend ahead. Wesfarmers’ half-year results will be the next key gauge of demand across its major retail chains and the remaining pricing power.

Wesfarmers, which owns Bunnings, Kmart Group, and Officeworks, also has interests in chemicals and fertilisers, industrial and safety, plus a health business. This diverse mix positions it as a key indicator for household spending and segments of the industrial cycle.

Australian shares closed the week at an 11-week peak, led mainly by banks, while materials lost steam following a record streak, AAP reported. “By and large, it’s been a really solid week … after a particularly good run by the big mining stocks,” said IG market analyst Tony Sycamore to AAP. Kyabram Free Press

The ASX cash market will be closed on Jan. 26 for Australia Day, according to the exchange’s trading calendar, with regular sessions leading up to that date. U.S. markets shut on Monday for Martin Luther King Jr. Day, often muting overseas signals early in the week.

Investors in Wesfarmers will be keenly watching for any insight into discretionary volumes following a turbulent period for consumer stocks. Attention centers on the resilience of the home-improvement division and whether discounting in general merchandise remains under control.

They’ll also watch for shifts in inventory and working capital — subtler clues about demand. Cash flow is crucial since it supports dividends and buybacks.

The risk is well-known: if households cut spending more sharply than predicted, margin pressure will surface quickly, particularly in areas relying on promotions. A sluggish start to 2026 might also refocus attention on costs over growth.

The stock often swings with shifts in bond yields and the Australian dollar, even when the company itself stays quiet. This pattern has shown up with other big consumer discretionary stocks as well.

Wesfarmers is set to release its half-year results and hold a briefing on Feb. 19. Traders will be watching closely for updates on how the company sees trading conditions shaping up in the second half.

Shan Ahmed Khan is a senior markets reporter at TS2.tech, specializing in stocks, technology and macroeconomic trends. A graduate of the Lahore University of Management Sciences (LUMS), he previously worked in investment research and market analysis. His coverage helps readers understand the key developments influencing global financial markets and emerging industries.

Stock Market Today

  • Nasdaq Jumps, Dow Hits 52,000 as Tech Names Rebound
    June 29, 2026, 4:52 PM EDT. U.S. stocks ended higher Monday, with Nasdaq up 1.84% as big tech names recovered. The Dow Jones Industrial Average finished above 52,000 for the first time, closing at 52,234.45, a gain of 0.69%. The S&P 500 advanced 1.07%. Alphabet Inc. surged 4.6% after replacing Verizon in the Dow. Market breadth was mixed. NYSE advancers outpaced decliners 1.31-to-1, but the S&P 500 saw no new 52-week highs. Citi flagged a rare momentum dip in the Magnificent Seven, which dropped 6% equal-weighted last week. Traders are watching June payrolls heading into the holiday. The market is keeping a cautious stance before earnings.
Bitcoin price nears $97,000 as ETF inflows rebound and Senate crypto bill stalls
Previous Story

Bitcoin price nears $97,000 as ETF inflows rebound and Senate crypto bill stalls

Merck stock slips as FDA fast-track questions build and earnings near
Next Story

Merck stock slips as FDA fast-track questions build and earnings near

Go toTop